North America Immunoassay Reagents and Devices Market - Industry Trends and Forecast To 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 DBMR VENDOR SHARE ANALYSIS

2.8 MULTIVARIATE MODELING

2.9 PRODUCT TIMELINE CURVE

2.10 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INDUSTRY INSIGHT

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF DISEASES

5.1.2 INCREASING APPLICATION OF DRUG SCREEINING TESTS

5.1.3 INCREASING HEALTHCARE EXPENDITURE

5.1.4 WIDE APPLICATION OF IMMUNOASSAY

5.2 RESTRAINTS

5.2.1 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES

5.2.2 STRINGENT REGULATIONS BY REGULATORY AUTHORITIES

5.2.3 HIGH COST ASSOCIATED WITH DEVICES

5.3 OPPORTUNITIES

5.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES

5.3.2 STRATEGIC INITATIVES BY THE COMPANIES

5.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY

5.4 CHALLENGES

5.4.1 LACK OF AWARENESS AND SKILLS REGARDING THE USAGE OF TECHNOLOGY

5.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY

5.4.3 AVAILABILITY OF SUBSTITUTE

6 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 REAGENTS & KITS

6.2.1 ELISA REAGENTS & KITS

6.2.1.1 THIRD-GENERATION ELISA

6.2.1.2 FIFTH-GENERATION ELISA

6.2.1.3 FOURTH-GENERATION ELISA

6.2.1.4 FIRST-GENERATION ELISA

6.2.1.5 SECOND-GENERATION ELISA

6.2.2 ELISPOT REAGENTS & KITS

6.2.3 RAPID TEST REAGENTS & KITS

6.2.4 WESTERN BLOT REAGENTS & KITS

6.2.5 OTHER REAGENTS & KITS

6.3 ANALYZERS

6.3.1 BY TYPE

6.3.1.1 OPEN-ENDED SYSTEMS

6.3.1.2 CLOSED-ENDED SYSTEMS

6.3.2 BY DEVICE TYPE

6.3.2.1 BENCH-TOP

6.3.2.2 FLOOR STANDING

7 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM

7.1 OVERVIEW

7.2 ENZYME IMMUNOASSAY

7.3 FLUORESCENCE IMMUNOASSAYS

7.4 CHEMILUMINESCENCE IMMUNOASSAYS

7.5 RADIOIMMUNOASSAYS

7.6 OTHERS

8 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE

8.1 OVERVIEW

8.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS

8.3 ENZYME-LINKED IMMUNOSPOT

8.4 RAPID TESTS

8.5 WESTERN BLOTTING

8.6 IMMUNO-PCR

8.7 OTHER TECHNIQUES

9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE

9.1 OVERVIEW

9.2 BLOOD

9.3 URINE

9.4 SALIVA

9.5 OTHERS

10 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 ONCOLOGY AND ENDOCRINOLOGY

10.3 HEMATOLOGY & BLOOD SCREENING

10.4 CARDIOLOGY

10.5 INFECTIOUS DISEASES

10.6 BONE & MINERAL DISORDERS

10.7 AUTOIMMUNE DISORDERS

10.8 TOXICOLOGY

10.9 NEONATAL SCREENING

10.10 OTHER APPLICATIONS

11 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER

11.1 OVERVIEW

11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

11.3 CLINICAL LABORATORIES

11.4 HOSPITALS

11.5 RESEARCH & ACADEMIC LABORATORIES

11.6 BLOOD BANKS

11.7 OTHERS

12 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY GEOGRAPHY

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 COMPANY PROFILES

14.1 F. HOFFMANN-LA ROCHE LTD

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 BIO-RAD LABORATORIES, INC.

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 BIOMÉRIEUX SA

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENT

14.4 ABBOTT

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 RANDOX LABORATORIES LTD.

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENT

14.6 AGILENT TECHNOLOGIES, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.7 LUMINEX CORPORATION

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 BD

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 BECKMAN COULTER, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENT

14.10 BIOCHECK, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 BIO-TECHNE

14.11.1 COMPANY SNAPSHOT

14.11.2 REVENUE ANALYSIS

14.11.3 PRODUCT PORTFOLIO

14.11.4 RECENT DEVELOPMENTS

14.12 DIASORIN S.P.A.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 MERCK KGAA

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENTS

14.14 MESO SCALE DIAGNOSTICS, LLC

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 ORTHO CLINICAL DIAGNOSTICS (A SUBSIDIARY OF CARLYLE INVESTMENT MANAGEMENT L.L.C)

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENT

14.16 PERKINELMER INC.

14.16.1 COMPANY SNAPSHOT

14.16.2 REVENUE ANALYSIS

14.16.3 PRODUCT PORTFOLIO

14.16.4 RECENT DEVELOPMENT

14.17 QIAGEN

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENT

14.18 QUIDEL CORPORATION

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENT

14.19 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.20 SIEMENS

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENTS

14.21 SYSMEX CORPORATION

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

14.22 THERMO FISHER SCIENTIFIC INC.

14.22.1 COMPANY SNAPSHOT

14.22.2 REVENUE ANALYSIS

14.22.3 PRODUCT PORTFOLIO

14.22.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

UU

TABLE 1 COST OF EIA KITS BY MERCK KGAA

TABLE 2 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 3 NORTH AMERICA REAGENTS AND KITS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 4 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 6 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 9 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 10 NORTH AMERICA ENZYME IMMUNOASSAY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 NORTH AMERICA FLUORESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 NORTH AMERICA CHEMILUMINESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 NORTH AMERICA RADIOIMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 NORTH AMERICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 16 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 NORTH AMERICA ENZYME-LINKED IMMUNOSPOT IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 NORTH AMERICA RAPID TESTS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 NORTH AMERICA WESTERN BLOTTING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 NORTH AMERICA IMMUNO-PCR IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 NORTH AMERICA OTHER TECHNIQUES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 23 NORTH AMERICA BLOOD IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 NORTH AMERICA URINE IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 NORTH AMERICA SALIVA IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 NORTH AMERICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 28 NORTH AMERICA ONCOLOGY AND ENDOCRINOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 NORTH AMERICA HEMATOLOGY & BLOOD SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 NORTH AMERICA CARDIOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 NORTH AMERICA INFECTIOUS DISEASES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 NORTH AMERICA BONE & MINERAL DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 NORTH AMERICA AUTOIMMUNE DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 NORTH AMERICA TOXICOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 35 NORTH AMERICA NEONATAL SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 36 NORTH AMERICA OTHER APPLICATIONS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 37 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 38 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 39 NORTH AMERICA CLINICAL LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 40 NORTH AMERICA HOSPITALS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 41 NORTH AMERICA RESEARCH & ACADEMIC LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 42 NORTH AMERICA BLOOD BANKS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 43 NORTH AMERICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 44 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 45 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 46 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 47 NORTH AMERICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 48 NORTH AMERICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 NORTH AMERICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 51 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 52 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 53 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 54 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 55 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 56 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 57 U.S. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 58 U.S. REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 U.S. ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 61 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 62 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 63 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 64 U.S. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 65 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 66 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 67 CANADA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 68 CANADA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 69 CANADA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 70 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 71 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 72 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 73 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 74 CANADA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 76 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 77 MEXICO ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 78 MEXICO REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 79 MEXICO ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 80 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 81 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 82 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 83 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 84 MEXICO IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)